While our biochemical studies indicate that FBXO11 inhibits the chromatin binding of SAMD1, the precise molecular mechanisms and how FBXO11 influences the biological role of SAMD1 in pancreatic cancer have not been fully elucidated in this study. This evidence concerns the gene FBXO11 and familial pancreatic carcinoma.